星空体育官方入口网站网址大全-登录入口官网

#遗传性血管性水肿#

8篇内容 | 1071人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2217605, encodeId=836d221e60584, content=<a href='/topic/show?id=8c9c95151f5' target=_blank style='color:#2F92EE;'>#遗传性血管性水肿#</a> <a href='/topic/show?id=f98d11e3122f' target=_blank style='color:#2F92EE;'>#胃肠道影像学#</a>, objectTitle=基于病例，破译HAE胃肠道影像学“密码”, objectType=article, longId=836137, objectId=ece083613e4e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240729/1722236145675_8538692.jpg, objectUrl=/article/show_article.do?id=ece083613e4e, replyNumber=0, likeNumber=5, createdTime=2024-07-30, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ece083613e4e, moduleTitle=基于病例，破译HAE胃肠道影像学“密码”, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ece083613e4e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2216448, encodeId=fb242216448c9, content=<a href='/topic/show?id=8c9c95151f5' target=_blank style='color:#2F92EE;'>#遗传性血管性水肿#</a> <a href='/topic/show?id=c01e85565e8' target=_blank style='color:#2F92EE;'>#腹痛#</a>, objectTitle=病例分享 | 反复腹痛、水肿，疾病沉疴20余年，罪魁祸首竟是罕见HAE, objectType=article, longId=835723, objectId=5be9835e23d4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240716/1721092170881_8538692.jpg, objectUrl=/article/show_article.do?id=5be9835e23d4, replyNumber=0, likeNumber=45, createdTime=2024-07-23, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=5be9835e23d4, moduleTitle=病例分享 | 反复腹痛、水肿，疾病沉疴20余年，罪魁祸首竟是罕见HAE, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5be9835e23d4)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2215553, encodeId=ad99221555349, content=<a href='/topic/show?id=8c9c95151f5' target=_blank style='color:#2F92EE;'>#遗传性血管性水肿#</a>, objectTitle=《新英格兰杂志》：Donidalorsen治疗遗传性血管性水肿的疗效和安全性, objectType=article, longId=835075, objectId=6c698350e555, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240718/1721272224921_2570354.jpg, objectUrl=/article/show_article.do?id=6c698350e555, replyNumber=0, likeNumber=16, createdTime=2024-07-18, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=6c698350e555, moduleTitle=《新英格兰杂志》：Donidalorsen治疗遗传性血管性水肿的疗效和安全性, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6c698350e555)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2208189, encodeId=16dc2208189a9, content=<a href='/topic/show?id=8c9c95151f5' target=_blank style='color:#2F92EE;'>#遗传性血管性水肿#</a>, objectTitle=首个LNP-mRNA体内遗传性血管性水肿（HAE）的基因编辑治疗，终身只需一次治疗!, objectType=article, longId=828697, objectId=49e282869e02, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20240529/41a210f99fc2451bb8bec13609e56023-pYxJmcFJUWXs.jpg, objectUrl=/article/show_article.do?id=49e282869e02, replyNumber=0, likeNumber=39, createdTime=2024-06-04, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=49e282869e02, moduleTitle=首个LNP-mRNA体内遗传性血管性水肿（HAE）的基因编辑治疗，终身只需一次治疗!, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=49e282869e02)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2188005, encodeId=c4c121880053e, content=<a href='/topic/show?id=8c9c95151f5' target=_blank style='color:#2F92EE;'>#遗传性血管性水肿#</a>, objectTitle=《新英格兰杂志》：遗传性血管性水肿KLKB1基因的CRISPR-Cas9体内基因编辑疗法, objectType=article, longId=813775, objectId=0126813e75bd, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240218/1708248186555_2570354.png, objectUrl=/article/show_article.do?id=0126813e75bd, replyNumber=0, likeNumber=50, createdTime=2024-02-18, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=0126813e75bd, moduleTitle=《新英格兰杂志》：遗传性血管性水肿KLKB1基因的CRISPR-Cas9体内基因编辑疗法, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0126813e75bd)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1215987, encodeId=0343121598ef6, content=<a href='/topic/show?id=8c9c95151f5' target=_blank style='color:#2F92EE;'>#遗传性血管性水肿#</a>, objectTitle=浙江有关遗传性血管性水肿调研出炉聚焦罕见病患者困境, objectType=article, longId=208022, objectId=3b102080221a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202137/1615048563796_2119349.jpg, objectUrl=/article/show_article.do?id=3b102080221a, replyNumber=0, likeNumber=75, createdTime=2022-05-01, rootId=0, userName=赛华佗, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b102080221a, moduleTitle=浙江有关遗传性血管性水肿调研出炉聚焦罕见病患者困境, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3b102080221a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1203685, encodeId=c3fd12036853c, content=<a href='/topic/show?id=8c9c95151f5' target=_blank style='color:#2F92EE;'>#遗传性血管性水肿#</a>, objectTitle=BioCryst启动BCX7353对遗传性血管性水肿患者的长期安全性试验, objectType=article, longId=131025, objectId=db211310250f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/webeditor/uploadfile/201802/20180228212812459.gif, objectUrl=/article/show_article.do?id=db211310250f, replyNumber=0, likeNumber=77, createdTime=2022-03-18, rootId=0, userName=医者仁者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=db211310250f, moduleTitle=BioCryst启动BCX7353对遗传性血管性水肿患者的长期安全性试验, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=db211310250f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1203683, encodeId=5bfe1203683a8, content=<a href='/topic/show?id=8c9c95151f5' target=_blank style='color:#2F92EE;'>#遗传性血管性水肿#</a>, objectTitle=NEJM：口服血浆激肽释放酶抑制剂预防遗传性血管性水肿, objectType=article, longId=145226, objectId=f633145226de, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/webeditor/uploadfile/201807/20180726094010969.jpg, objectUrl=/article/show_article.do?id=f633145226de, replyNumber=0, likeNumber=90, createdTime=2022-03-18, rootId=0, userName=医者仁者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f633145226de, moduleTitle=NEJM：口服血浆激肽释放酶抑制剂预防遗传性血管性水肿, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=f633145226de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1203682, encodeId=d26c1203682ed, content=<a href='/topic/show?id=8c9c95151f5' target=_blank style='color:#2F92EE;'>#遗传性血管性水肿#</a>, objectTitle=EAACI 2020：长期临床数据证实Berotralstat可稳定持久地减少遗传性血管性水肿患者的发作, objectType=article, longId=195487, objectId=d55819548e54, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/type2diabetes-s18-plaque-in-artery.jpg, objectUrl=/article/show_article.do?id=d55819548e54, replyNumber=0, likeNumber=86, createdTime=2022-03-18, rootId=0, userName=医者仁者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d55819548e54, moduleTitle=EAACI 2020：长期临床数据证实Berotralstat可稳定持久地减少遗传性血管性水肿患者的发作, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=d55819548e54)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1203681, encodeId=cfce1203681c8, content=<a href='/topic/show?id=8c9c95151f5' target=_blank style='color:#2F92EE;'>#遗传性血管性水肿#</a>, objectTitle=NEJM：反义疗法治疗遗传性血管性水肿，初见有效性端倪, objectType=article, longId=200190, objectId=fc1e200190f9, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202093/1599098739359_5295902.jpeg, objectUrl=/article/show_article.do?id=fc1e200190f9, replyNumber=0, likeNumber=96, createdTime=2022-03-18, rootId=0, userName=医者仁者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc1e200190f9, moduleTitle=NEJM：反义疗法治疗遗传性血管性水肿，初见有效性端倪, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=fc1e200190f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1203680, encodeId=59a912036805e, content=<a href='/topic/show?id=8c9c95151f5' target=_blank style='color:#2F92EE;'>#遗传性血管性水肿#</a>, objectTitle=日本厚生劳动省（MHLW）批准ORLADEYO（贝罗司他）用于遗传性血管性水肿的预防性治疗, objectType=article, longId=206188, objectId=8ad420618870, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2021124/1611460988466_5295902.jpeg, objectUrl=/article/show_article.do?id=8ad420618870, replyNumber=0, likeNumber=118, createdTime=2022-03-18, rootId=0, userName=医者仁者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8ad420618870, moduleTitle=日本厚生劳动省（MHLW）批准ORLADEYO（贝罗司他）用于遗传性血管性水肿的预防性治疗, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=8ad420618870)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1203679, encodeId=b9f512036e9e7, content=<a href='/topic/show?id=8c9c95151f5' target=_blank style='color:#2F92EE;'>#遗传性血管性水肿#</a>, objectTitle=Lancet：Garadacimab可有效预防C1酯酶抑制剂缺乏性遗传性血管性水肿患者的水肿发作, objectType=article, longId=299975, objectId=14d32999e546, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202232/1646226459373_2110107.png, objectUrl=/article/show_article.do?id=14d32999e546, replyNumber=0, likeNumber=84, createdTime=2022-03-18, rootId=0, userName=医者仁者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=14d32999e546, moduleTitle=Lancet：Garadacimab可有效预防C1酯酶抑制剂缺乏性遗传性血管性水肿患者的水肿发作, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=14d32999e546)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1203678, encodeId=6f3812036e83f, content=<a href='/topic/show?id=8c9c95151f5' target=_blank style='color:#2F92EE;'>#遗传性血管性水肿#</a>, objectTitle=NEJM：Donidalorsen可降低遗传性血管性水肿发作风险改善患者生活质量, objectType=article, longId=301024, objectId=986030102477, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2022317/1647498065823_2051781.png, objectUrl=/article/show_article.do?id=986030102477, replyNumber=0, likeNumber=123, createdTime=2022-03-18, rootId=0, userName=医者仁者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=986030102477, moduleTitle=NEJM：Donidalorsen可降低遗传性血管性水肿发作风险改善患者生活质量, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=986030102477)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

遗传性血管性水肿

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#遗传性血管性水肿# #胃肠道影像学#

基于病例，破译HAE胃肠道影像学“密码”

2024-07-30发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#遗传性血管性水肿# #腹痛#

病例分享 | 反复腹痛、水肿，疾病沉疴20余年，罪魁祸首竟是罕见HAE

2024-07-23发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#遗传性血管性水肿#

《新英格兰杂志》：Donidalorsen治疗遗传性血管性水肿的疗效和安全性

2024-07-18发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#遗传性血管性水肿#

首个LNP-mRNA体内遗传性血管性水肿（HAE）的基因编辑治疗，终身只需一次治疗!

2024-06-04发表于威斯康星

梅斯管理员 (审核中...)

前往app查看评论内容

#遗传性血管性水肿#

《新英格兰杂志》：遗传性血管性水肿KLKB1基因的CRISPR-Cas9体内基因编辑疗法

2024-02-18发表于上海

赛华佗 (审核中...)

前往app查看评论内容

#遗传性血管性水肿#

浙江有关遗传性血管性水肿调研出炉聚焦罕见病患者困境

2022-05-01

医者仁者 (审核中...)

前往app查看评论内容

#遗传性血管性水肿#

BioCryst启动BCX7353对遗传性血管性水肿患者的长期安全性试验

2022-03-18

医者仁者 (审核中...)

前往app查看评论内容

#遗传性血管性水肿#

NEJM：口服血浆激肽释放酶抑制剂预防遗传性血管性水肿

2022-03-18

医者仁者 (审核中...)

前往app查看评论内容

#遗传性血管性水肿#

EAACI 2020：长期临床数据证实Berotralstat可稳定持久地减少遗传性血管性水肿患者的发作

2022-03-18

医者仁者 (审核中...)

前往app查看评论内容

#遗传性血管性水肿#

NEJM：反义疗法治疗遗传性血管性水肿，初见有效性端倪

2022-03-18

医者仁者 (审核中...)

前往app查看评论内容

#遗传性血管性水肿#

日本厚生劳动省（MHLW）批准ORLADEYO（贝罗司他）用于遗传性血管性水肿的预防性治疗

2022-03-18

医者仁者 (审核中...)

前往app查看评论内容

#遗传性血管性水肿#

Lancet：Garadacimab可有效预防C1酯酶抑制剂缺乏性遗传性血管性水肿患者的水肿发作

2022-03-18

医者仁者 (审核中...)

前往app查看评论内容

#遗传性血管性水肿#

NEJM：Donidalorsen可降低遗传性血管性水肿发作风险改善患者生活质量

2022-03-18

科室
- - 订阅+
  - 更多科室
工具
服务